X0306 4 2022-03-01 false 0001603756 Axonics, Inc. AXNX 0001756438 Dearen Danny L. 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false See Remarks Common Stock 2022-03-01 4 M false 12329.00 25.82 A 40564.00 D Common Stock 2022-03-01 4 S false 1500.00 56.3166 D 39064.00 D Common Stock 2022-03-01 4 S false 7846.00 57.395 D 31218.00 D Common Stock 2022-03-01 4 S false 10564.00 58.1137 D 20654.00 D Stock Options (Right to buy) 25.82 2022-03-01 4 M false 12329.00 0.00 D 2029-12-12 Common Stock 12329.00 2343.00 D The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $55.82 to $56.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $56.84 to $57.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $57.85 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date. /s/ Danny L. Dearen 2022-03-03